Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor

被引：43

作者：

Yip, Y ^{[1
]}

Victor, F ^{[1
]}

Lamar, J ^{[1
]}

Johnson, R ^{[1
]}

Wang, QM ^{[1
]}

Barket, D ^{[1
]}

Glass, J ^{[1
]}

Jin, L ^{[1
]}

Liu, LF ^{[1
]}

Venable, D ^{[1
]}

Wakulchik, M ^{[1
]}

Xie, CP ^{[1
]}

Heinz, B ^{[1
]}

Villarreal, E ^{[1
]}

Colacino, J ^{[1
]}

Yumibe, N ^{[1
]}

Tebbe, M ^{[1
]}

Munroe, J ^{[1
]}

Chen, SH ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Div A, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 01期

关键词：

D O I：

10.1016/j.bmcl.2003.09.074

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe herein the design, syntheses and evaluation of a number of bicycloproline P2 bearing HCV protease inhibitors endowed with impressive enzyme potency, enzyme selectivity, cellular activity and favorable ADME profiles. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：251 / 256

页数：6

共 30 条

[11] α-ketoamides, α-ketoesters and α-diketones as HCVNS3 protease inhibitors
Han, W
Hu, ZL
Jiang, XJ
Decicco, CP
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (08) : 711 - 713
[12] Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
Heathcote, EJ
Shiffman, ML
Cooksley, WGE
Dusheiko, GM
Lee, SS
Balart, L
Reindollar, R
Reddy, RK
Wright, TL
Lin, A
Hoffman, J
De Pamphilis, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23) : 1673 - 1680
[13] Prime site binding inhibitors of a serine protease:: NS3/4A of hepatitis C virus
Ingallinella, P
Fattori, D
Altamura, S
Steinkühler, C
Koch, U
Cicero, D
Bazzo, R
Cortese, R
Bianchi, E
Pessi, A
[J]. BIOCHEMISTRY, 2002, 41 (17) : 5483 - 5492
[14] Hepatitis C virus NS3/4A protease
Kwong, AD
Kim, JL
Rao, G
Lipovsek, D
Raybuck, SA
[J]. ANTIVIRAL RESEARCH, 1998, 40 (1-2) : 1 - 18
[15] Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
Lohmann, V
Körner, F
Koch, JO
Herian, U
Theilmann, L
Bartenschlager, R
[J]. SCIENCE, 1999, 285 (5424) : 110 - 113
[16] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
McHutchison, JG
Gordon, SC
Schiff, ER
Shiffman, ML
Lee, WM
Rustgi, VK
Goodman, ZD
Ling, MH
Cort, S
Albrecht, JK
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) : 1485 - 1492
[17] A CONCISE, STEREOCONTROLLED THIAZOLIUM YLIDE APPROACH TO KAINIC ACID
MONN, JA
VALLI, MJ
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (10) : 2773 - 2778
[18] KINETICS OF REVERSIBLE INHIBITION OF ENZYME-CATALYSED REACTIONS BY TIGHT-BINDING INHIBITORS
MORRISON, JF
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1969, 185 (02) : 269 - &
[19] Inhibitors of hepatitis C virus NS3•4A protease 1.: Non-charged tetrapeptide variants
Perni, RB
Britt, SD
Court, JC
Courtney, LF
Deininger, DD
Farmer, LJ
Gates, CA
Harbeson, SL
Kim, JL
Landro, JA
Levin, RB
Luong, YP
O'Malley, ET
Pitlik, J
Rao, BG
Schairer, WC
Thomson, JA
Tung, RD
Van Drie, JH
Wei, YY
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (22) : 4059 - 4063
[20] Solid-phase synthesis of peptidomimetic inhibitors for the hepatitis C virus NS3 protease
Poupart, MA
Cameron, DR
Chabot, C
Ghiro, E
Goudreau, N
Goulet, S
Poirier, M
Tsantrizos, YS
[J]. JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (14) : 4743 - 4751

← 1 2 3 →